Elevation of Plasma Milrinone Concentrations in Stage D Heart Failure Associated With Renal Dysfunction
Conclusion:
Patients with stage D HF having severe renal dysfunction have elevated milrinone concentrations. Future studies of milrinone concentrations are warranted to investigate the potential risk of life-threatening arrhythmias and potential dosing regimens in renal dysfunction.
Source: Journal of Cardiovascular Pharmacology and Therapeutics - Category: Cardiology Authors: Cox, Z. L., Calcutt, M. W., Morrison, T. B., Akers, W. S., Davis, M. B., Lenihan, D. J. Tags: Clinical Studies Source Type: research
More News: Arrhythmia | Cardiac Catheterization | Cardiology | Cardiovascular | Databases & Libraries | Dialysis | Drugs & Pharmacology | Heart | Heart Failure | Hemodialysis | Study | Ventricular Tachycardia